NDC 52584-353
LINCOMYCIN
Lincomycin Hydrochloride
LINCOMYCIN is a Intramuscular; Intravenous; Subconjunctival Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by General Injectables And Vaccines, Inc.. The primary component is Lincomycin Hydrochloride.
| Product ID | 52584-353_121cb853-ab09-459c-b5ea-ab2c8535a240 |
| NDC | 52584-353 |
| Product Type | Human Prescription Drug |
| Proprietary Name | LINCOMYCIN |
| Generic Name | Lincomycin Hydrochloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS; SUBCONJUNCTIVAL |
| Marketing Start Date | 2020-11-06 |
| Marketing End Date | 2023-07-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA201746 |
| Labeler Name | General Injectables and Vaccines, INC. |
| Substance Name | LINCOMYCIN HYDROCHLORIDE |
| Active Ingredient Strength | 300 mg/mL |
| NDC Exclude Flag | N |